Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Annovis Bio Inc.

    NYSE: ANVS · Real-Time Price · USD
    2.83
    -0.11 (-3.74%)
    At close: Jun 13, 2025, 3:59 PM
    2.90
    2.65%
    After-hours: Jun 13, 2025, 07:59 PM EDT

    Annovis Bio Statistics

    Share Statistics

    Annovis Bio has 19.49M shares outstanding. The number of shares has increased by 74.43% in one year.

    Shares Outstanding

    n/a
    		 19.49M

    Shares Change (YoY)

    n/a
    		 74.43%

    Shares Change (QoQ)

    n/a
    		 41.23%

    Owned by Institutions (%)

    n/a
    		 12.14%

    Shares Floating

    n/a
    		 16.65M

    Failed to Deliver (FTD) Shares

    n/a
    		 22,759

    FTD / Avg. Volume

    n/a
    		 5.14%

    Short Selling Information

    The latest short interest is 2.11M, so 10.85% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.11M

    Short % of Shares Out

    n/a
    		 10.85%

    Short % of Float

    n/a
    		 12.65%

    Short Ratio (days to cover)

    n/a
    		 4.09

    Valuation Ratios

    PE Ratio

    n/a
    		 0

    Forward PE

    n/a
    		 -1.84

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.3

    PB Ratio

    n/a
    		 6.58

    P/FCF Ratio

    n/a
    		 0

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Annovis Bio.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.59, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 3.59

    Quick Ratio

    n/a
    		 3.59

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-3,073,796,875

    Employee Count

    n/a
    		 8

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -24.57B

    Effective Tax Rate

    n/a
    		 99.9%

    Stock Price Statistics

    The stock price has increased by -51.62% in the last 52 weeks. The beta is 1.62, so Annovis Bio's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.62

    52-Week Price Change

    n/a
    		 -51.62%

    50-Day Moving Average

    n/a
    		 1.88

    200-Day Moving Average

    n/a
    		 4.72

    Relative Strength Index (RSI)

    n/a
    		 60.26

    Average Volume (20 Days)

    n/a
    		 442,663

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -26.7M

    Net Income

    n/a
    		 -24.59B

    EBITDA

    n/a
    		 -22.74M

    EBIT

    n/a
    		 -22.74M

    Earnings Per Share (EPS)

    n/a
    		 -2018.5
    Full Income Statement

    Balance Sheet

    The company has 10.55M in cash and 0 in debt, giving a net cash position of 10.55M.

    Cash & Cash Equivalents

    n/a
    		 10.55M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -134.85M

    Total Assets

    n/a
    		 26.74M

    Working Capital

    n/a
    		 24.23M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -21.89B and capital expenditures 0, giving a free cash flow of -21.89B.

    Operating Cash Flow

    n/a
    		 -21.89B

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -21.89B

    FCF Per Share

    n/a
    		 -1797.22
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    ANVS does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ANVS is $19, which is 571.4% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $19

    Price Target Difference

    n/a
    		 571.4%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 6
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 2

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist